EMVISION MEDICAL DEVICES LIMITED (EMV)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EMV - EMVISION MEDICAL DEVICES LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.07
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.29

15 Apr
2024

-0.020

OPEN

$2.29

-0.87%

HIGH

$2.36

48,822

LOW

$2.25

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 20192020202120222023
EPS Basic xxxxxxxxxxxx-5.0
DPS All xxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxx-
Book Value Per Share xxxxxxxxxxxx6.6
Net Operating Cash Flow xxxxxxxxxxxx0.8 M
Net Profit Margin xxxxxxxxxxxx-

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20192020202120222023
Return on Capital Employed xxxxxxxxxxxx-63.47 %
Return on Invested Capital xxxxxxxxxxxx-59.32 %
Return on Assets xxxxxxxxxxxx-38.66 %
Return on Equity xxxxxxxxxxxx-63.47 %
Return on Total Capital xxxxxxxxxxxx-136.81 %
Free Cash Flow ex dividends xxxxxxxxxxxx0.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20192020202120222023
Short-Term Debt xxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxx0 M
Total Debt xxxxxxxxxxxx3 M
Goodwill - Gross xxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxx10 M
Price To Book Value xxxxxxxxxxxx17.82

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20192020202120222023
Capex xxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxx-
Cost of Goods Sold xxxxxxxxxxxx0 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxx11 M
Research & Development xxxxxxxxxxxx2 M
Investments - Total xxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

EMV STOCK CHART